Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71205-015

5 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71205-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-015-90 (Valsahctz 320 25mg)

71205-015-90 (Valsahctz 320 25mg)
Label for Valsartan HCTZ 320 mg / 25 mg tablets, film-coated, with a quantity of 90 tablets. The label indicates this product is RX only and lists the manufacturer as Alembic Pharmaceuticals Limited, India. It includes storage instructions and notes that tablets are yellow, oval-shaped, and debossed with 'L239'. The relabeler is Proficient Rx LP, Thousand Oaks, CA.*
FDA Label Image

Figure 1 (Valsahctz Figur1)

Figure 1 (Valsahctz Figur1)
A line graph showing the probability of achieving systolic blood pressure (SBP) below 140 mmHg at week 8, plotted against baseline SBP (140-180 mmHg). Four lines represent different treatments: Valsartan and hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The combination tablet shows the highest probability across baseline SBP values.*
FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Figure 2-3-4 (Valsahctz Figure2 3 4)
This image contains three line graphs displaying the probability of achieving specific blood pressure targets at Week 8 for Valsartan and Hydrochlorothiazide 320/25 mg tablets versus Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The graphs plot baseline diastolic or systolic blood pressure (mmHg) on the x-axis against the percentage probability of achieving targeted blood pressure thresholds on the y-axis for each treatment group.*
FDA Label Image

Structure (Valsahctz Hctz)

Structure (Valsahctz Hctz)
Chemical structure diagram of the active ingredient in the Valsartan and Hydrochlorothiazide combination tablet.*
FDA Label Image

Structure (Valsahctz Valsa)

Structure (Valsahctz Valsa)
Chemical structure diagram of Valsartan, one of the active ingredients in Valsartan and Hydrochlorothiazide tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.